{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-026477","form_type":"8-K","ticker":"CLDI","cik":"0001855485","company_name":"Calidi Biotherapeutics, Inc.","filed_at":"2024-07-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.959141+00:00","generated_at":"2026-05-31T23:08:18.189421+00:00","sec_items":["1.01","2.03","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Calidi Biotherapeutics secures $600K loan at 15% interest from Dennis Conklin","bullets":["Loan agreement with Dennis R. Conklin for principal amount of $600,000.","Note bears simple interest at 15% per annum, matures three years from July 2, 2024.","Interest payable annually after each calendar year; principal and remaining interest due at maturity.","Proceeds received on July 2, 2024; use of proceeds not specified."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-026477","json":"https://secwatch.observer/filing/0001493152-24-026477.json","markdown":"https://secwatch.observer/filing/0001493152-24-026477.md","text":"https://secwatch.observer/filing/0001493152-24-026477.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1855485/000149315224026477/0001493152-24-026477-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1855485/000149315224026477/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T23:08:18.189421+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}